Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$113,016,568
+$40,808,950 QoQ
Shares Held
4,658,556
0.0% QoQ
Ownership
4.49%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#9
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,876,485,415 across 78 Biotechnology names. NRIX ranks #21 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $113,016,568 | 4,658,556 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $72,207,618 | 4,658,556 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $88,372,807 | 4,658,556 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,870,835 | 3,882,125 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $44,217,403 | 3,882,125 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $46,119,645 | 3,882,125 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $73,139,235 | 3,882,125 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $87,231,348 | 3,882,125 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $81,019,948 | 3,882,125 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,067,237 | 3,882,125 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $40,063,530 | 3,882,125 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $30,513,502 | 3,882,125 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $38,782,428 | 3,882,125 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $34,473,270 | 3,882,125 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $42,625,732 | 3,882,125 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $50,584,088 | 3,882,125 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $49,186,523 | 3,882,125 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,381,688 | 2,454,082 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $71,045,673 | 2,454,082 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $73,524,296 | 2,454,082 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $65,106,795 | 2,454,082 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $76,297,409 | 2,454,082 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $58,819,722 | 1,788,921 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $62,451,232 | 1,788,921 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||